Altimmune Inc (ALT)
7.31
+0.12
(+1.67%)
USD |
NASDAQ |
May 03, 16:00
7.31
0.00 (0.00%)
After-Hours: 18:54
Altimmune Market Cap: 518.24M for May 3, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 02, 2024 | 509.74M |
| May 01, 2024 | 501.23M |
| April 30, 2024 | 464.36M |
| April 29, 2024 | 453.38M |
| April 26, 2024 | 514.70M |
| April 25, 2024 | 510.45M |
| April 24, 2024 | 501.94M |
| April 23, 2024 | 536.68M |
| April 22, 2024 | 529.59M |
| April 19, 2024 | 489.89M |
| April 18, 2024 | 488.47M |
| April 17, 2024 | 499.10M |
| April 16, 2024 | 533.13M |
| April 15, 2024 | 535.26M |
| April 12, 2024 | 566.45M |
| April 11, 2024 | 595.52M |
| April 10, 2024 | 567.87M |
| April 09, 2024 | 595.52M |
| April 08, 2024 | 610.41M |
| April 05, 2024 | 644.44M |
| April 04, 2024 | 630.97M |
| April 03, 2024 | 658.62M |
| April 02, 2024 | 663.23M |
| April 01, 2024 | 725.26M |
| March 28, 2024 | 721.71M |
| Date | Value |
|---|---|
| March 27, 2024 | 630.26M |
| March 26, 2024 | 613.24M |
| March 25, 2024 | 604.74M |
| March 22, 2024 | 643.73M |
| March 21, 2024 | 643.87M |
| March 20, 2024 | 660.13M |
| March 19, 2024 | 617.72M |
| March 18, 2024 | 641.75M |
| March 15, 2024 | 696.88M |
| March 14, 2024 | 708.54M |
| March 13, 2024 | 771.09M |
| March 12, 2024 | 768.26M |
| March 11, 2024 | 697.59M |
| March 08, 2024 | 734.34M |
| March 07, 2024 | 708.89M |
| March 06, 2024 | 805.02M |
| March 05, 2024 | 794.41M |
| March 04, 2024 | 780.99M |
| March 01, 2024 | 854.49M |
| February 29, 2024 | 855.20M |
| February 28, 2024 | 938.60M |
| February 27, 2024 | 976.05M |
| February 26, 2024 | 800.07M |
| February 23, 2024 | 650.23M |
| February 22, 2024 | 626.91M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
23.47M
Minimum
Nov 19 2019
1.099B
Maximum
Sep 02 2022
360.71M
Average
365.52M
Median
Market Cap Benchmarks
| Eli Lilly and Co | 699.08B |
| Amgen Inc | 166.92B |
| Pfizer Inc | 157.53B |
| Viking Therapeutics Inc | 8.485B |
| Precision BioSciences Inc | 71.76M |
Market Cap Related Metrics
| PS Ratio | 913.54 |
| Price to Book Value | 2.670 |
| Price | 7.31 |
| Earnings Yield | -22.85% |